Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.8 USD
8.57%
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Other Equity
|
Adaptive Biotechnologies Corp
Other Equity Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Other Equity
-$106k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other Equity
-$3.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-50%
|
|
|
Danaher Corp
NYSE:DHR
|
Other Equity
-$2.7B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Other Equity
-$298.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-25%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other Equity
-$316m
|
CAGR 3-Years
12%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other Equity
-$867m
|
CAGR 3-Years
-62%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
See Also
What is Adaptive Biotechnologies Corp's Other Equity?
Other Equity
-106k
USD
-106k
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Other Equity amounts to -106k USD.
What is Adaptive Biotechnologies Corp's Other Equity growth rate?
Other Equity CAGR 1Y
94%
94%
Over the last year, the Other Equity growth was 94%.
You don't have any saved screeners yet
